GB202316444D0 - Salts of opicapone - Google Patents
Salts of opicaponeInfo
- Publication number
- GB202316444D0 GB202316444D0 GBGB2316444.5A GB202316444A GB202316444D0 GB 202316444 D0 GB202316444 D0 GB 202316444D0 GB 202316444 A GB202316444 A GB 202316444A GB 202316444 D0 GB202316444 D0 GB 202316444D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- opicapone
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HVGGGVAREUUJQV-CHHVJCJISA-N (4z)-4-[3-(2,5-dichloro-4,6-dimethyl-1-oxidopyridin-1-ium-3-yl)-2h-1,2,4-oxadiazol-5-ylidene]-2-hydroxy-6-nitrocyclohexa-2,5-dien-1-one Chemical class CC1=C(Cl)C(C)=[N+]([O-])C(Cl)=C1C(NO1)=N\C1=C\1C=C([N+]([O-])=O)C(=O)C(O)=C/1 HVGGGVAREUUJQV-CHHVJCJISA-N 0.000 title 1
- 229950001673 opicapone Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2316444.5A GB202316444D0 (en) | 2023-10-27 | 2023-10-27 | Salts of opicapone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2316444.5A GB202316444D0 (en) | 2023-10-27 | 2023-10-27 | Salts of opicapone |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202316444D0 true GB202316444D0 (en) | 2023-12-13 |
Family
ID=89073437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2316444.5A Pending GB202316444D0 (en) | 2023-10-27 | 2023-10-27 | Salts of opicapone |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202316444D0 (en) |
-
2023
- 2023-10-27 GB GBGB2316444.5A patent/GB202316444D0/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202010882XA (en) | Salts of an fgfr inhibitor | |
EP4069212A4 (en) | Inhibitors of hif-2alpha | |
EP4112054A4 (en) | Use of csf-1r kinase inhibitor | |
IL288484A (en) | Crystalline salt forms of a kinase inhibitor | |
IL300040A (en) | Solid state forms of belumosudil and belumosudil salts | |
IL282454A (en) | Crystalline salts of a plasma kallikrein inhibitor | |
GB202204778D0 (en) | Novel crystalline salt forms of mesembrine | |
EP4190774A4 (en) | Solid form of compound | |
SI3749673T1 (en) | Crystalline form of bictegravir sodium | |
GB202401487D0 (en) | Salts and polymorphs of mitragynine and 3-deuteromitragynine | |
GB202316444D0 (en) | Salts of opicapone | |
GB202215863D0 (en) | Preparation of neosaxitoxin | |
IL277578A (en) | Novel salt forms of urat-1 inhibitors | |
GB201912411D0 (en) | Crystalline forms of ivosidenib | |
GB202211269D0 (en) | Salts | |
GB202009218D0 (en) | Crystalline forms of entrectinib | |
GB202002054D0 (en) | Crystalline forms of entrectinib | |
EP4151639A4 (en) | Crystalline salt of eribulin | |
GB202203181D0 (en) | Inhibitors of elF4A | |
GB202107612D0 (en) | Inhibitors of metallo-beta-lactamases | |
GB202215264D0 (en) | Use of urolithins | |
GB202103774D0 (en) | Detectiion of Ransomware | |
GB202013382D0 (en) | Production of inorganic salts | |
GB202114327D0 (en) | Uses of terpenophenolic compounds | |
IL304402A (en) | Advantageous morphic form of at-527 hemi-sulfate salt |